Aspirin-triggered lipoxin A4 (15-epi-LXA4) increases the endothelial viability of human corneas storage in Optisol-GS

Journal of Ocular Pharmacology and Therapeutics

Volumn 27, Issue 3, 2011, Pages 235-241

  He, Jiucheng ^a   Kakazu, Azucena H ^a   Bazan, Nicolas G ^a   Bazan, Haydee E P ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELL MARKER; CYCLOOXYGENASE 2; LIPOXIN A; MONOCLONAL ANTIBODY KI 67; POLYCLONAL ANTIBODY;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA; CORNEA ENDOTHELIUM; DESCEMET MEMBRANE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHONDROITIN SULFATES; COMPLEX MIXTURES; CORNEA; DEXTRANS; ENDOTHELIUM, CORNEAL; EYE BANKS; FEMALE; GENTAMICINS; HUMANS; LIPOXINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; ORGAN PRESERVATION SOLUTIONS; PHOSPHOPROTEINS; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; TISSUE PRESERVATION;

EID: 79958825526     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2010.0187     Document Type: Article

References (35)

1. Edelhauser, H.F. The balance between corneal transparency and edema: the Proctor lecture. Invest. Opthalmol. Vis. Sci. 47:1754-1767, 2006.
2. Bimbaun, F., Reinhard, T., Bohhringer, D., et al. Endothelial cell loss after autologous rotational keratoplasty. Graefes Arch. Clin. Exp. Opthalmol. 243:57-59, 2005.
3. Wilhelmus, K.R., Stulting, R.D., Sugar, J., and Khan, M.M. Primary corneal graft failure. A national reporting system. Medical Advisory Board of the Eye Bank Association of America. Arch. Opthalmol. 113:1497-1502, 1995.
4. Clerhout, I., Beele, H., and Kestelyn, P. Graft failure: I. Endothelial loss. Int. Opthalmol. 28:165-173, 2008.
5. Bourne, W.M. Cellular changes in transplanted human corneas. Cornea 20:560-569, 2001. (Pubitemid 32706188)
6. Bourne, W.M., Nelson, L.R., and Hodge, D.O. Central corneal endothelial cell changesover a ten-year period. Invest. Opthalmol. Vis. Sci. 38:779-782, 1997. (Pubitemid 27143150)
7. Pels, E., Beekhuis, H., and Volker-Dieben, H.J. Long term tissue storage for keratoplasty. In: Brighbill, F.S., ed. Corneal Surgery, Theory, Technique and Tissue, 3rd edition. St Louis: Mosby, Inc.; 1999; p. 897-906.
8. Lindstrom, R.L., Kaufman, H.E., Skelnik, D.L., et al. Optisol corneal storage medium. Am. J. Opthalmol. 114:345-356, 1992.
9. Nejepinska, J., Juklova, K., and Jirsova, K. Organ culture, but not hypothermic storage, facilitates the repair of the corneal endothelium following mechanical damage. Acta. Opthalmol. 88:413-419, 2010.
10. Serhan, C.N. Lipoxin and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins 53:107-137, 1997. (Pubitemid 27171542)
11. Serhan, C.N., Gotlinger, K., Hong, S., and Arita, M. Resolvins, docosatrienes and neuroprotectins, novel o-3derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat. 73:155-172, 2004. (Pubitemid 38757795)
12. Serhan, C.N. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?. Am. J. Pathol. 177:1576-1591, 2010.
13. Chiang, N., Serhan, C., Sven-Erik, D., et al. The lipoxin receptor ALX: a potent ligand-specific and stereoselective actions in vivo. Pharmacol. Rev. 58:463-487, 2006. (Pubitemid 44394909)
14. Ye, R.D., Boulay, F., Wang, J.M., et al. International Union of Basic and Clinical Pharmacology. LXXIII nomenclature for the formyl peptide receptor (FPR) family. Pharmacol. Rev. 61:119-161, 2009.
15. Takano, T., Fiore, S., Maddox, J.F., et al. Aspirin-triggered 15-Epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for antiinflammatory receptors. J. Exp. Med. 185:1693-1704, 1997. (Pubitemid 27203265)
16. Armitage, W.J., Dick, A.D., and Bourne, W.M. Predicting endothelial cell loss and long term corneal graft survival. Invest. Opthalmol. Vis. Sci. 44:3326-3331, 2003. (Pubitemid 36909766)
17. Joyce, N.C. Proliferative capacity of the corneal endothelium. Prog. Retin. Eye Res. 22:359-389, 2003. (Pubitemid 38352553)
18. Wilson, S.E., Walker, J.W., He, Y.G., and McCash, C.S. Extended life of human corneal endothelial cells transfected with the SV40 large T antigen. Invest. Opthalmol. Vis. Sci. 34:2112-2123, 1993. (Pubitemid 23148651)
19. Feldman, S.T., Gjerset, R., Gately, D., et al. Expression of SV40 virus large antigen by recombinant adenoviruses activates proliferation of corneal endothelium in vitro. J. Clin. Invest. 91:1713-1720, 1993. (Pubitemid 23127377)
20. Pistov, M.Y., Sadovnikova, E., and Danilov, S.M. Human corneal endothelial cells: isolation, characterization and long term cultivation. Exp. Eye Res. 47:403-414, 1988.
21. Johnstone, E.W., Wong, H.C., Coster, D.J., and Williams, K.A. Factors affecting bovine corneal endothelial cell density in vitro. Br. J. Opthalmol. 80:256-262, 1996. (Pubitemid 26090355)
22. Senoo, T., Obara, Y., and Joyce, N.C. EDTA: a promoter of proliferation in human corneal endothelium. Invest. Opthalmol. Vis. Sci. 41:2930-2935, 2000.
23. Lu, X., Chen, D., Liu, Z., et al. Enhanced survival in vitro of human corneal endothelial cells using mouse embryonic stem cell conditioned medium. Mol. Vis. 16:611-622, 2010.
24. Gronert, K., Gewirtz, A., Madara, J.L., and Serhan, C.N. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interlukin (IL)-13 and interferon g and inhibits tumor necrosis factor a-induced IL-8 release. J. Exp. Med. 187:1285-1294, 1998. (Pubitemid 28189117)
25. Gronert, K., Masheshwari, N., Khan, N., Hassan, I.R., Dunn, M., and Schwartzman, M.L. A role for the mouse 12/15- lipoxygenease pathway in promoting epithelial wound healing and host defense. J. Biol. Chem. 280:15267-15278, 2005. (Pubitemid 40562883)
26. Biteman, B., Hassan, I.R., Walker, E., et al. Interdependence of lipoxin A4 and heme-oxygenease in counter-regulating inflammation during corneal wound healing. FASEB J. 21:2257-2266, 2007. (Pubitemid 47026460)
27. Jin, Y., Arita, M., Zhang, Q., et al. Anti-angiogenesis effect of the novel anti-inflammatory and proresolving lipid mediators. Invest. Opthalmol. Vis. Sci. 50:4743-4752, 2009.
28. Leedom, A.J., Sullivan, A.B., Dong, B., et al. Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury. Am. J. Pathol. 176:74-84, 2010.
29. Madeiros, R., Rodrigues, G.B., Figueiredo, C.P., et al. Molecular mechanisms of topical anti-inflammatory effects of lipoxin A(4) in endotoxin-induced uveitis. Mol. Pharmacol. 74:154-161, 2008. (Pubitemid 351872166)
30. Karim, M.J., Bhattacherjee, P., Biswas, S., and Paterson, C.A. Anti-inflammatory effects of lipoxins on lipopolysaccharideinduced uveitis in rats. J. Ocul. Pharmacol. Ther. 25:483-486, 2009.
31. Borderie, V.M., Baudrimont, M., Lopez, M., et al. Evaluation of the deswelling period in dextran-containig medium after corneal organ culture. Cornea 16:215-223, 1997. (Pubitemid 27131586)
32. Pels, E., and Schuchard, Y. Organ culture preservation of human corneas. Doc. Opthalmol. 15:147-153, 1983. (Pubitemid 14199882)
33. Means, T.L., Geroski, D.H., Hadley, A., et al. Viability of human corneal endothelium following Optisol-GS storage. Arch. Opthalmol. 113:805-809, 1995.
34. Armitage, W.J., and Easty, D.L. Factors influencing the suitability of organ-cultures corneas for transplantation. Invest. Opthalmol. Vis. Sci. 38:16-24, 1997. (Pubitemid 27051520)
35. Engelman, K., Bednarz, J., and Valtink, M. Prospects for endothelial transplantation. Exp. Eye Res. 78:573-578, 2004. (Pubitemid 38183336)